🔗 Share this article

The Nobel Prize in medical science was awarded for transformative discoveries that clarify how the immune system targets harmful infections while sparing the healthy tissues.

Three renowned researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this honor.

The work uncovered unique "security guards" within the defense system that eliminate rogue defense cells that could attacking the body.

The discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.

These laureates will share a monetary award valued at 11 million Swedish kronor.

Decisive Findings

"The research has been essential for understanding how the body's defenses functions and why we don't all suffer from serious self-attack conditions," commented the head of the Nobel Committee.

The trio's studies address a fundamental question: In what way does the immune system protect us from numerous infections while keeping our healthy cells unharmed?

Our immune system employs immune cells that search for signs of disease, including viruses and germs it has never encountered.

These defenders employ detectors—called receptors—that are generated by chance in a vast number of variations.

This gives the immune system the capacity to combat a wide array of threats, but the randomness of the mechanism unavoidably produces white blood cells that can attack the host.

Security Guards of the Immune System

Researchers previously understood that some of these problematic defense cells were eliminated in the thymus—the site where white blood cells develop.

The latest Nobel Prize honors the discovery of regulatory T-cells—described as the body's "peacekeepers"—which patrol the system to neutralize other immune cells that assault the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee added, "The findings have established a new field of investigation and spurred the creation of innovative treatments, for instance for cancer and immune disorders."

In malignancies, T-regs block the system from attacking the growth, so research are focused on reducing their numbers.

For self-attack disorders, trials are testing increasing regulatory T-cells so the body is not under attack. A similar method could also be useful in minimizing the chances of organ transplant rejection.

Innovative Experiments

Professor Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their thymus removed, leading to autoimmune disease.

He demonstrated that introducing immune cells from healthy animals could stop the disease—implying there was a mechanism for blocking defenders from attacking the body.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an inherited immune disorder in rodents and humans that resulted in the identification of a gene vital for how T-regs operate.

"Their pioneering work has uncovered how the immune system is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," commented a prominent physiology specialist.

"This research is a remarkable illustration of how fundamental physiological study can have broad consequences for human health."